North Carolina woman pleads guilty to selling unapproved Covid-19 remedies | USAO-NH

CONCORD- Diana Daffin, 69, of Charlotte, North Carolina, pleaded guilty in federal court to selling unapproved drugs with the intent to defraud or mislead the FDA, the FDA announced today. American lawyer Jane E. Young.

According to court documents and statements made in court, Diana Daffin owned and operated a holistic medicine company called Savvy Holistic Health doing business as Holistic Healthy Pet. In March 2020, the Food and Drug Administration (FDA) learned that Daffin was selling unapproved drugs on its website, under the brand name HAMPL, which Daffin claimed were COVID-19 cures and treatments. In April and August 2020, the FDA sent warning letters to Daffin explaining that various products it was selling – including HAMPL COVID-19 drugs – were adulterated, mislabeled, and unapproved drugs and that it should take immediate action to correct the violation. Daffin responded by telling the FDA that it had removed the products from its website and would stop distributing them.

However, Daffin did not stop selling the products. Instead, it continued to distribute unapproved COVID-19 drugs and took steps to defraud and mislead the FDA. For example, she continued to sell unapproved HAMPL-brand drugs by moving them to a password-protected website, telling a customer it was her “way to evade the FDA.”

In February 2021, Daffin sold an undercover law enforcement agent a HAMPL product that she advertised as a drug that could cure, mitigate, treat, and prevent COVID-19 in humans. In an email leading up to the sale, Daffin told the undercover officer, “This stuff works for covid, but the fda shut it down.” Daffin then sold and shipped the unapproved HAMPL brand COVID-19 drug and other unapproved drugs to the undercover agent.

On March 5, 2021, the New Hampshire undercover agent received HAMPL drugs sold by Daffin, including the purported COVID-19 cure. The label said it offered “stronger CV immunity” and promised “immunity for humans”.

Daffin is scheduled to be sentenced on November 2, 2022.

This case was investigated by the United States Food and Drug Administration – Office of Criminal Investigations, Homeland Security Investigations and the United States Postal Inspection Service. The case is being prosecuted by Assistant U.S. Attorneys Matthew T. Hunter and Georgiana L. MacDonald.


On May 17, 2021, the Attorney General established the COVID-19 Fraud Enforcement Task Force to mobilize Department of Justice resources in partnership with government agencies to scale up enforcement and prevention efforts. pandemic-related fraud. The task force strengthens efforts to investigate and prosecute the most culpable domestic and international criminal actors and assists agencies administering relief programs to prevent fraud, among other methods, by increasing and integrating coordination mechanisms existing ones, identifying resources and techniques to uncover fraudulent actors and their agendas, and sharing and leveraging information and knowledge gained from previous enforcement efforts. For more information about the Department’s response to the pandemic, please visit

Anyone with information about alleged attempted fraud involving COVID-19 can report it by calling the Department of Justice’s National Center for Disaster Fraud (NCDF) hotline at 866-720-5721 or via NCDF’s online complaint form at: https://www.


About Patrick K. Moon

Check Also

The best-selling books of the week

Reading room The best-selling New Zealand books of the week, as recorded by the Nielsen …